Nuclear androgen receptor as marker of responsiveness to medroxyprogesterone acetate in human renal cell carcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000378:metabolism*; D011944:Receptors, Androgen / Q000378:metabolism*; D011987:Receptors, Steroid / Q000378:metabolism*
D011944:Receptors, Androgen; D011987:Receptors, Steroid; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone